Prescriptions made by Ronald A ZielinskI

Data for 2018

2,369

Medicare Part D Prescriptions Filled, Including Refills

Rank: 163 out of 719 providers in this state and specialty

$1.58M

Total Retail Price of All Prescriptions

Rank: 43 out of 719 providers in this state and specialty

408

Patients Receiving at Least One Drug in Part D

Rank: 82 out of 719 providers in this state and specialty

91%

Patients 65 Years and Older

74

Average Age of Patients

Average age of patients for providers in this state and specialty is 72

Drug Categories

O

Opioid

An opioid drug. Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.
A

Antibiotic

Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.
P

Antipsychotic

Used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders.

Prescription Data

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume. Rank in State ranks all providers that have the self-identified specialty of Pulmonary Disease in New York and ranks the number of prescriptions that have been made for the specific drug.

Drug Name Rank in State Total Prescriptions Filled with Refills Prescript. to 65+ Patients Receiving this Drug Patients 65+ OAP
1 BREO ELLIPTA
(FLUTICASONE/VILANTEROL)
380
of 4880
3140 prescriptions
Less than 1% of all prescriptions
2670880 patients
22% of all patients
770 patients
19% of all patients
2 MONTELUKAST SODIUM1390
of 5230
1180 prescriptions
Less than 1% of all prescriptions
960370 patients
9% of all patients
< 11
3 ADVAIR DISKUS
(FLUTICASONE PROPION/SALMETEROL)
1030
of 5490
1140 prescriptions
Less than 1% of all prescriptions
920400 patients
10% of all patients
< 11
4 SPIRIVA
(TIOTROPIUM BROMIDE)
750
of 5050
1190 prescriptions
Less than 1% of all prescriptions
390 patients
10% of all patients
< 11
5 ANORO ELLIPTA
(UMECLIDINIUM BRM/VILANTEROL TR)
470
of 4570
1530 prescriptions
Less than 1% of all prescriptions
1530460 patients
11% of all patients
460 patients
11% of all patients
6 PREDNISONE530
of 5580
2380 prescriptions
Less than 1% of all prescriptions
21701210 patients
30% of all patients
< 11
7 VENTOLIN HFA
(ALBUTEROL SULFATE)
1250
of 5820
1010 prescriptions
Less than 1% of all prescriptions
820470 patients
12% of all patients
< 11
8 AZELASTINE HCL170
of 1680
810 prescriptions
Less than 1% of all prescriptions
430 patients
11% of all patients
< 11
9 PROAIR HFA
(ALBUTEROL SULFATE)
870
of 5330
1040 prescriptions
Less than 1% of all prescriptions
560 patients
14% of all patients
< 11
10 STIOLTO RESPIMAT
(TIOTROPIUM BR/OLODATEROL HCL)
190
of 1870
760 prescriptions
Less than 1% of all prescriptions
240 patients
6% of all patients
< 11
11 INCRUSE ELLIPTA
(UMECLIDINIUM BROMIDE)
1070
of 4930
880 prescriptions
Less than 1% of all prescriptions
430230 patients
6% of all patients
< 11
12 FLUTICASONE PROPIONATE800
of 4500
670 prescriptions
Less than 1% of all prescriptions
530240 patients
6% of all patients
< 11
13 ARNUITY ELLIPTA
(FLUTICASONE FUROATE)
280
of 1840
640 prescriptions
Less than 1% of all prescriptions
510210 patients
5% of all patients
< 11
14 MOMETASONE FUROATE20
of 780
680 prescriptions
Less than 1% of all prescriptions
260 patients
6% of all patients
< 11
15 ASMANEX
(MOMETASONE FUROATE)
40
of 750
700 prescriptions
Less than 1% of all prescriptions
700170 patients
4% of all patients
170 patients
4% of all patients
16 OFEV
(NINTEDANIB ESYLATE)
90
of 890
540 prescriptions
Less than 1% of all prescriptions
540< 11< 11
17 AZITHROMYCIN890
of 4410
580 prescriptions
Less than 1% of all prescriptions
580180 patients
4% of all patients
180 patients
4% of all patients
A
18 PULMICORT FLEXHALER
(BUDESONIDE)
180
of 870
240 prescriptions
Less than 1% of all prescriptions
240< 11< 11
19 SYMBICORT
(BUDESONIDE/FORMOTEROL FUMARATE)
2070
of 5720
250 prescriptions
Less than 1% of all prescriptions
250< 11< 11
20 SPIRIVA RESPIMAT
(TIOTROPIUM BROMIDE)
1150
of 3750
290 prescriptions
Less than 1% of all prescriptions
140 patients
3% of all patients
< 11
21 FLOVENT DISKUS
(FLUTICASONE PROPIONATE)
200
of 840
270 prescriptions
Less than 1% of all prescriptions
< 11< 11
22 DYMISTA
(AZELASTINE/FLUTICASONE)
50
of 250
200 prescriptions
Less than 1% of all prescriptions
200110 patients
3% of all patients
110 patients
3% of all patients
23 TRELEGY ELLIPTA
(FLUTICASONE/UMECLIDIN/VILANTER)
580
of 2030
180 prescriptions
Less than 1% of all prescriptions
< 11< 11
24 DALIRESP
(ROFLUMILAST)
480
of 1740
240 prescriptions
Less than 1% of all prescriptions
240< 11< 11
25 THEOPHYLLINE
(THEOPHYLLINE ANHYDROUS)
190
of 540
160 prescriptions
Less than 1% of all prescriptions
< 11< 11
26 HYDROXYCHLOROQUINE SULFATE60
of 140
130 prescriptions
Less than 1% of all prescriptions
130< 11< 11
27 ALPRAZOLAM460
of 1100
180 prescriptions
Less than 1% of all prescriptions
180< 11< 11
28 COMBIVENT RESPIMAT
(IPRATROPIUM/ALBUTEROL SULFATE)
630
of 1950
130 prescriptions
Less than 1% of all prescriptions
< 11< 11
29 MYCOPHENOLATE MOFETIL160
of 350
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
30 ARALAST NP
(ALPHA-1-PROTEINASE INHIBITOR)
20
of 140
260 prescriptions
Less than 1% of all prescriptions
00< 1100 patients
Less than 1% of all patients
31 ESBRIET
(PIRFENIDONE)
340
of 940
110 prescriptions
Less than 1% of all prescriptions
110< 11< 11
32 IPRATROPIUM BROMIDE450
of 1100
130 prescriptions
Less than 1% of all prescriptions
< 11< 11
33 DOXYCYCLINE MONOHYDRATE60
of 250
340 prescriptions
Less than 1% of all prescriptions
250 patients
6% of all patients
< 11A
34 ZOLPIDEM TARTRATE600
of 1440
170 prescriptions
Less than 1% of all prescriptions
170120 patients
3% of all patients
120 patients
3% of all patients
35 SULFAMETHOXAZOLE-TRIMETHOPRIM
(SULFAMETHOXAZOLE/TRIMETHOPRIM)
320
of 930
120 prescriptions
Less than 1% of all prescriptions
< 11< 11A
36 CEFPODOXIME PROXETIL70
of 110
170 prescriptions
Less than 1% of all prescriptions
170130 patients
3% of all patients
130 patients
3% of all patients
A